Stay well informed about transactions in the global life sciences industry
Register now:
Current Issue:
The new edition of our newsletter on transactions in the global chemicals industry glances back at the significant deals that took place in 2025 and provides further insights on the industry’s market trends.
- Deal volume: Global chemicals M&A activity improved in 2025, with deal volume up 2% Y‑o‑Y and deal value rising 45%, driven by steady interest in small and mid‑cap strategic acquisitions and a handful of megadeals.
- M&A drivers: Portfolio restructuring, regional consolidation, and demand for sustainable and specialty assets supported deal momentum as companies balanced geopolitical pressures with strategic growth.
- Corporate acquisitions: Strategic buyers sustained activity through carve‑outs and bolt‑on deals aimed at streamlining operations, reinforcing core capabilities, advancing vertical integration, and strengthening supply‑chain control and cost synergies.
- PE activity: Private equity activity grew 2.4% Y‑o‑Y and represented 38% of all deals, with investors deploying dry powder while holding existing assets for better valuations.
- Localization: Rising geopolitical and tariff risks accelerated regionalization, with domestic transactions accounting for 67% of M&A activity as companies pursued more resilient supply chains and expanded local production in vulnerable markets such as the US.
Your contact
Christian Klingbeil
Partner, Deal Advisory, Valuation, Head of Life Sciences & Chemicals
KPMG AG Wirtschaftsprüfungsgesellschaft